Institut National de la Recherche Agronomique, Nutrition Humaine et Sécurité Alimentaire, 147 rue de l'Université, 75338 Paris Cedex 07, France.
Eur J Nutr. 2009 Dec;48 Suppl 1:S33-9. doi: 10.1007/s00394-009-0074-2.
It is amazing to see how much the approach of the food risk analysis evolved in the recent years. For half a century and the birth of the risk assessment methodology in the food domain, only no appreciable health risk was considered acceptable by the manager. This is the vocabulary used in the case of a voluntary, deliberated human action, as the use of food additives (definition of ADI). In the case of risks not resulting from such an action, as that of the presence of contaminants, the risk assessor allocates provisional tolerable daily, weekly or monthly intake that are the basis for regulation. This vocabulary is in agreement with the objective which consists in approaching closer possible of the zero risk which is the wish of a majority of the consumers. Some years ago, the risk managers insisted to obtain from the assessors as often as possible a quantitative risk evaluation. More recently even, the managers would like to decide on the basis of a balance of risk and benefit acceptable for management purposes. Finally, they hope that general principles and tools will be available for conducting a quantitative risk-benefit analysis for foods and food ingredients. What is possible in the case of functional foods (FF)? Based on the definition of FF proposed in the programme FUFOSE, one has to distinguish between different situations in order to assess the risk: that of a micro-, that of a macro-component or that of a whole food. These situations have been clearly described in the document resulting from FOSIE. The standardized methodology relevant to assess micro-components is not well adapted to the assessment of whole food. Concepts of substantial equivalence and of history of safe use could be useful tools in this case. However, quantitative risk assessment remains a very difficult exercise. If a process for the assessment of health benefit of FF has been proposed as an outcome of the PASSCLAIM action, the quantification of this benefit needs adequate tools. An EFSA scientific colloquium on "Risk-Benefit Analysis of Foods" organized in July 2006 concluded that the risk-benefit analysis should mirror the current risk analysis paradigm and that its assessment should be performed with common scales. Disability adjusted life years (DALYs) or quality adjusted life years (QUALYs) have been proposed as some of these common scales. However, the meeting "concluded that the data available to undertake a quantitative risk-benefit assessment may be too scarce". Because it was considered that it was premature to formulate guidelines on good risk-benefit analysis practice and it is now time to "learning by doing", a reference to the upcoming ILSI Europe project BRAFO was done. All these aspects are discussed, in particular in relation to the specific case of FF.
看到食品风险分析方法在近年来取得了多大的进展,真是令人惊讶。在半个世纪以来,食品领域风险评估方法诞生之际,只要没有明显的健康风险,管理者就认为是可以接受的。这是在自愿、深思熟虑的人类行为的情况下使用的词汇,例如食品添加剂的使用(ADI 的定义)。在不是由于这种行为造成的风险的情况下,例如污染物的存在,风险评估员会分配临时可耐受的每日、每周或每月摄入量,作为监管的基础。这种词汇与目标一致,即尽可能接近大多数消费者所希望的零风险。几年前,风险管理者坚持要求评估人员尽可能多地进行定量风险评估。最近,管理者甚至希望根据管理目的可接受的风险和收益平衡来做出决策。最后,他们希望能够获得一般原则和工具,以便对食品和食品成分进行定量风险-收益分析。功能性食品(FF)方面可能吗?根据 FUFOSE 计划中提出的 FF 定义,必须区分不同情况,以便评估风险:微观、宏观成分或整个食品。这些情况在 FOSIE 产生的文件中得到了清楚的描述。用于评估微观成分的标准化方法不太适合评估整个食品。实质性等效和安全使用历史的概念在这种情况下可能是有用的工具。然而,定量风险评估仍然是一项非常困难的工作。如果作为 PASSCLAIM 行动的结果提出了评估 FF 健康益处的过程,那么就需要适当的工具来量化这种益处。2006 年 7 月,欧洲食品安全局(EFSA)组织了一次关于“食品风险-收益分析”的科学座谈会,结论是风险-收益分析应该反映当前的风险分析范式,其评估应该使用共同的尺度进行。残疾调整生命年(DALYs)或质量调整生命年(QUALYs)已被提议作为其中一些共同尺度。然而,会议“得出结论,进行定量风险-收益评估可用的数据可能太少”。由于认为制定良好的风险-收益分析实践指南还为时过早,现在是“边做边学”的时候了,因此提到了即将进行的 ILSI 欧洲项目 BRAFO。本文特别讨论了所有这些方面,特别是与 FF 的具体情况有关的方面。